Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Trump signs executive order to help reshore pharmaceutical manufacturing

By Chris Newmarker | August 10, 2020

Trump Whirlpool reshore pharmaceuticals

“We’ll be making our product here safely, beautifully, and inexpensively,” Trump said during an Aug. 6 event at a Whirlpool factory in Ohio. [Image pulled from White House video]

President Donald Trump recently signed an executive order meant to encourage the reshoring of pharmaceutical manufacturing to the U.S.

The executive order, signed Aug. 6, includes “buy American” provisions for U.S. government agencies’ procurement of essential medicines and reduces regulatory provisions.

The Secretary of Health and Human Services and FDA commissioner, consistent with applicable law, will also accelerate FDA approvals and clearances for domestic producers of medicines and medical countermeasures, issue guidance for advanced manufacturing techniques and increase inspections of manufacturing facilities outside the U.S.

“During the course of the next four years, we will bring our pharmaceutical and medical supply chains home,” Trump said during an Aug. 6 appearance at a Whirlpool washing machine factory in Clyde, Ohio. “We’re going to bring them home where they belong. And we’ll end reliance on China, just like we did with the washers and dryers, just like we did with many other things. We’ll be making our product here safely, beautifully, and inexpensively.”

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Tell Us What You Think! Cancel reply

Related Articles Read More >

This is the logo of Abbvie.
AbbVie acquires drug delivery manufacturing plant in Arizona
Apiject Logo
Apiject to open new injectable drug manufacturing facility in North Carolina
BD Neopak XtraFlow glass prefillable syringe (1)
BD to invest $110M to support prefilled syringe production, pharma supply chain
Samsung Biologics GSK Rockville Maryland plant (1)
Samsung Biologics acquires GSK manufacturing site
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE